First Permanent Pacemaker Implantations in Burundi: A Case Series of three Patients in a Resource-Limited Setting
Abstract
Access to permanent pacemaker implantation remains limited in many low-income countries despite its life-saving role in symptomatic bradyarrhythmias. We describe two cases of symptomatic bradyarrhythmia and one case of pacemaker generator replacement managed at Tanganyika Hospital, Burundi. Clinical presentations included complete atrioventricular block and paroxysmal bradycardia confirmed by ECG and Holter monitoring. Permanent pacemaker implantation was performed via transvenous subclavian access under fluoroscopic guidance. Active fixation leads were used for atrial and ventricular positioning. One patient required generator replacement due to battery depletion of a device implanted abroad. All procedures were successful without complications. Device interrogation confirmed appropriate function in all patients. Clinical symptoms resolved rapidly, and discharge occurred within 1–2 days. This case series highlights the feasibility and safety of establishing a local pacemaker implantation programme in a resource-limited setting.
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.